Samsung Electronics is expanding the scope of wearable device applications from daily health management to the realm of medical research by utilizing biometric data collected by the Galaxy Watch in clinical trials for new drug development.

Samsung Electronics announced on the 24th that it formed a partnership with Alcedis, a company specializing in data-based digital clinical trials, on the 23rd.

The two companies have agreed to jointly devise a plan to utilize biometric data collected from real-life environments using Galaxy Watch sensors as indicators for clinical trials in new drug development.

Alchedis is a German company specializing in digital clinical trials established in 1992, and has been conducting clinical trials in various fields such as oncology, cardiology, and neurology for over 30 years.

Currently, as a subsidiary of the global healthcare AI company Huma Group, it is driving the digital transformation of clinical research.

Samsung Electronics explained that the digital transformation of clinical research through wearable technology can increase data reliability by collecting biometric data in real time during daily life and increase clinical participation rates by reducing the burden of patients visiting hospitals.

The two companies will jointly develop a method to convert biometric data collected by Galaxy Watch sensors into clinical indicators to evaluate the efficacy and safety of new drugs.

also We plan to cooperate throughout the entire clinical research process, from data collection and monitoring of research participants to clinical trial operations and regulatory compliance.

Choi Jong-min, Senior Vice President of the Health Development Group at Samsung Electronics' MX Business Division, said, “We have been supporting researchers with various development tools, such as the Samsung Health SDK,” adding, “Through this collaboration, we will ensure that everyday data leads to results for new drug development research and patients.”

Samsung Electronics announced that it is building a 'Connected Care' ecosystem that links health data based on wearable devices with actual medical services.

To this end, it acquired Xealth, a platform company that connects digital healthcare solutions with over 500 large hospitals in the United States.

Based on this, Samsung Electronics announced plans to support prevention-oriented, personalized medical care by linking health data from Galaxy devices with hospital electronic medical record (EHR) systems.